Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
Jan 28, 2025, 4:00 PM EST

Oncotelic Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
111518631914
Upgrade
Market Cap Growth
-30.84%-13.24%-71.94%225.64%34.48%-
Upgrade
Enterprise Value
232727702115
Upgrade
Last Close Price
0.030.040.040.170.210.17
Upgrade
PE Ratio
--3.45---
Upgrade
PS Ratio
-218.13--11.06-
Upgrade
PB Ratio
1.291.310.927.691.540.85
Upgrade
P/TBV Ratio
1.412.492.40---
Upgrade
EV/Sales Ratio
-384.58--12.14-
Upgrade
Debt / Equity Ratio
1.591.080.591.100.370.06
Upgrade
Asset Turnover
-0.00--0.07-
Upgrade
Quick Ratio
0.010.010.020.040.040.03
Upgrade
Current Ratio
0.010.020.020.040.060.04
Upgrade
Return on Equity (ROE)
-48.63%-53.28%34.20%-101.92%-67.88%-68.55%
Upgrade
Return on Assets (ROA)
-1.01%-1.07%-11.74%-24.13%-20.02%-20.39%
Upgrade
Return on Capital (ROIC)
-1.26%-1.29%-14.73%-33.27%-27.09%-26.51%
Upgrade
Earnings Yield
-40.85%-51.76%28.95%-14.97%-49.34%-46.35%
Upgrade
FCF Yield
-11.82%-8.65%-8.25%-7.07%-14.60%-15.92%
Upgrade
Buyback Yield / Dilution
-2.81%13.37%-50.88%-244.02%-46.93%-877.11%
Upgrade
Total Shareholder Return
-2.81%13.37%-50.88%-244.02%-46.93%-877.11%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.